Sun, Jul 5, 2020
OPEN ACCESS
Volume 2, Issue 4 (OCTOBER 2003)                   Payesh 2003, 2(4): 293-298 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Seroprevalence of hepatitis C and risk factors in hemodialysis patients in Guilan Province, Iran. Payesh. 2003; 2 (4) :293-298
URL: http://payeshjournal.ir/article-1-830-en.html
Abstract:   (4136 Views)
Objective(s): To determine HCV infection in hemodialysis patients in Guilan, Iran.
Material & Methods: In this cross-sectional study, all 298 hemodialysis patients with regard to their sex, age length of time on dialysis and previous kidney transplantation were evaluated in Guilan Province. Blood samples screened for anti HCV antibodies by a second generation Enzyme-Linked Immunosorbent Assay (ELISA TI). Positive samples were retested for confirmatory immunoblotting assay. Analysis were carried out using the Epi6 software.
Results: An overall prevalence of 24.8% (95%CI: 19.9-29.7) was found, ranging from 9% to 40% depending on the dialysis unit. Of the 298 cases, 80 were found to be seropositive by ELISA and 74 were confirmed positive by Western blot assay.
The relationship between sex, age and seropositive results was not significant but relationship between length of time on dialysis and history of kidney rejection with seropositive results was significant.  Eleven patients had rejected kidney. Of these 7 cases were seropositive.
Conclusion: These data suggest that nasocomial transmission may play a role in the spreed of HCV in the dialysis units. A separate hemodialysis system should be used for seropositive HCV patients.
Full-Text [PDF 197 kb]   (1580 Downloads)    
Type of Study: Research | Subject: Medical
Accepted: 2018/11/28 | Published: 2003/10/15

Add your comments about this article : Your username or Email:
CAPTCHA

© 2015 All Rights Reserved | Payesh (Health Monitor)

Designed & Developed by : Yektaweb